Sivanesam Kalkena, Andersen Niels H
Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
Curr Neuropharmacol. 2016;14(3):226-37. doi: 10.2174/1570159x13666151030103153.
Alpha-Synuclein is found in the neuronal cells but its native function is not well known. While α -synuclein is an intrinsically disordered protein that adopts a helical conformation upon membrane binding, numerous studies have shown that oligomeric β-forms of this protein are cytotoxic. This response to misfolded species contributes to Parkinson's Disease etiology and symptoms. The resulting amyloid fibrils are an established diagnostic in Parkinson's Disease. In this review, we focus on strategies that have been used to inhibit the amyloidogenesis of α -synuclein either by stabilizing the native state, or by redirecting the pathway to less toxic aggregates. Small molecules such as polyphenols, peptides as well as large proteins have proven effective at protecting cells against the cytotoxicity of α-synuclein. These strategies may lead to the development of therapeutic agents that could prove useful in combating this disease.
α-突触核蛋白存在于神经元细胞中,但其天然功能尚不清楚。虽然α-突触核蛋白是一种内在无序的蛋白质,在与膜结合时会形成螺旋构象,但大量研究表明,该蛋白的寡聚β形式具有细胞毒性。这种对错误折叠物种的反应导致了帕金森病的病因和症状。由此产生的淀粉样纤维是帕金森病的一种既定诊断指标。在这篇综述中,我们重点关注了通过稳定天然状态或通过将途径重定向至毒性较小的聚集体来抑制α-突触核蛋白淀粉样蛋白生成的策略。小分子如多酚、肽以及大蛋白质已被证明能有效保护细胞免受α-突触核蛋白的细胞毒性。这些策略可能会导致开发出对对抗这种疾病有用的治疗药物。